Citation Impact
Citing Papers
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Beta-2 Adrenergic Activation of L-Type Ca++ Current in Cardiac Myocytes
1997
Beta-adrenoceptors in cardiac disease
1993
Structure of a mammalian ryanodine receptor
2014 StandoutNatureNobel
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Altered Beta-adrenergic Receptor Gene Regulation and Signaling in Chronic Heart Failure
2001
β-Adrenergic and Muscarinic Receptor Expression are Regulated in Opposite Ways During Senescence in Rat Left Ventricle
1997
?-Adrenergic receptors in failing human myocardium
1996
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Reduced beta 1 receptor messenger RNA abundance in the failing human heart.
1993
Implantable Left Ventricular Assist Devices
1998
The Failing Heart — An Engine Out of Fuel
2007 Standout
Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases.
1998
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
β2-Adrenergic Receptor-induced p38 MAPK Activation Is Mediated by Protein Kinase A Rather than by Gi or Gβγ in Adult Mouse Cardiomyocytes
2000 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Aging Biology and Geriatric Clinical Pharmacology
2004
Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic Receptors
1997 StandoutNobel
Heat Stroke
2002 Standout
Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy
1993
High levels of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in serum of rheumatoid arthritis patients and their normalization after anti–tumor necrosis factor α treatment
2002
Inflammatory Bowel Disease
2009 Standout
GIPC Interacts with the β1-Adrenergic Receptor and Regulates β1-Adrenergic Receptor-mediated ERK Activation
2003 StandoutNobel
Increased Osteoprotegerin Serum Levels in Men with Coronary Artery Disease
2003
G-protein-coupled receptor kinases and the heart
1995
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery
1999 StandoutNobel
Cardiac adrenergic receptor effects of carvedilol
1996
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Phosphorylation and Desensitization of the Human β1-Adrenergic Receptor
1995 StandoutNobel
Decreased accumulation of β1-adrenergic receptor, Gαs and total myosin heavy chain messenger RNAs in the left ventricle of senescent rat heart
1993
Improved Mortality and Rehabilitation of Transplant Candidates Treated with a Long-Term Implantable Left Ventricular Assist System
1995
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation
1993
Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes.
1997 StandoutNobel
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy
1992
Mechanism of Action of Beta-Blocking Agents in Heart Failure
1997
Why does the myocardium fail? Insights from basic science
1998
Regulation of myocardial βARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing α1B-adrenergic receptors
2001 StandoutNobel
β1-Adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy?
2000
Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice
1998 StandoutNobel
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Caveolar Localization Dictates Physiologic Signaling of β2-Adrenoceptors in Neonatal Cardiac Myocytes
2002 StandoutNobel
Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents
1993
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Production and Actions of Estrogens
2002 Standout
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
1994
Functional Coupling of Overexpressed β1-Adrenoceptors in the Myocardium of Transgenic Mice
1998
Inhibition of Spontaneous β2-Adrenergic Activation Rescues β1-Adrenergic Contractile Response in Cardiomyocytes Overexpressing β2-Adrenoceptor
2000 StandoutNobel
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Age-Dependent Changes in Cardiac Muscarinic Receptor Function in Healthy Volunteers
1997
Treatment of Infections Associated with Surgical Implants
2004 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)
2000 Standout
Cardiac excitation–contraction coupling
2002 StandoutNature
The Molecular Basis for Distinct β-Adrenergic Receptor Subtype Actions in Cardiomyocytes
1999
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Assessment of adrenergic neuron function altered with progression of heart failure.
1995
Coordinate Changes in Myosin Heavy Chain Isoform Gene Expression Are Selectively Associated With Alterations in Dilated Cardiomyopathy Phenotype
2002
Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice
2008
Creatine Kinase System in Failing and Nonfailing Human Myocardium
1996
RANK Ligand and Osteoprotegerin
2002
Targeting G βγ signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis
1999 StandoutNobel
A role for gastrointestinal endotoxins in enhancement of heat tolerance by physical fitness
1998
β-Adrenergic Receptor Blockade in Chronic Heart Failure
2000
Comparative Hemodynamic, Left Ventricular Functional, and Antiadrenergic Effects of Chronic Treatment With Metoprolol Versus Carvedilol in the Failing Heart
1996
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
β-Adrenergic Receptor Blockers Restore Cardiac Calcium Release Channel (Ryanodine Receptor) Structure and Function in Heart Failure
2001
Essential role of β-adrenergic receptor kinase 1 in cardiac development and function
1996 StandoutNobel
Localization of Osteoprotegerin, Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand, and Receptor Activator of Nuclear Factor-κB Ligand in Monckeberg’s Sclerosis and Atherosclerosis
2004
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Reduced Contraction and Altered Frequency Response of Isolated Ventricular Myocytes From Patients With Heart Failure
1995
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
1987 StandoutScience
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
1998 Standout
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
1996
Restoring Cardiac Function: An Emerging Spectrum of Therapeutic Options
1986
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Cardiac Function in Mice Overexpressing the β-Adrenergic Receptor Kinase or a βARK Inhibitor
1995 StandoutScienceNobel
The Intestinal Microvasculature as a Therapeutic Target in Inflammatory Bowel Disease
2006
Improved Left Ventricular Mechanics From Acute VDD Pacing in Patients With Dilated Cardiomyopathy and Ventricular Conduction Delay
1999
Preparation and characterization of a mouse osteoclast-like multinucleated cell population
1992
Augmentation of Cardiac Contractility Mediated by the Human β 3 -Adrenergic Receptor Overexpressed in the Hearts of Transgenic Mice
2001 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
NF-κB p50 and p52 Expression Is Not Required for RANK-Expressing Osteoclast Progenitor Formation but Is Essential for RANK- and Cytokine-Mediated Osteoclastogenesis
2002
Selective Downregulation of the Angiotensin II AT1-Receptor Subtype in Failing Human Ventricular Myocardium
1997
Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the β1-adrenergic receptor
1999 StandoutNobel
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Avian osteoclasts as estrogen target cells.
1991
In Vivo Inhibition of Elevated Myocardial β-Adrenergic Receptor Kinase Activity in Hybrid Transgenic Mice Restores Normal β-Adrenergic Signaling and Function
1999 StandoutNobel
Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure
1995
Vascular Calcification
2008 Standout
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
Level of β-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload–Induced Heart Failure
2005 StandoutNobel
Works of Fred Anderson being referenced
Basic Fibroblast Growth Factor Stimulates Osteoclast Recruitment, Development, and Bone Pit Resorption in Association With Angiogenesis In Vivo on the Chick Chorioallantoic Membrane and Activates Isolated Avian Osteoclast Resorption In Vitro
2002
Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
1992
Receptor Activator of NF-κB and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis
2001
Clinical Use of the Total Artificial Heart
1984
Isolation of avian osteoclasts: Improved techniques to preferentially purify viable cells
1991
Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation.
1992
Age-related changes in beta-adrenergic neuroeffector systems in the human heart.
1994
Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.
1991
Vasoactive intestinal peptide receptor in failing human ventricular myocardium exhibits increased affinity and decreased density.
1989
Effect of phenoxybenzamine on indomethacin induced systemic vasoconstriction in dogs
1985